Infectologia
Painel do FDA direciona-se para vacinas anuais de COVID
31 Jan, 2023 | 12:30hFDA panel eyes shift to annual COVID shots – CIDRAP
Ver também:
FDA advisers recommend updating Covid vaccines – STAT
U.S. Proposes to Make COVID Shot Annual, Much Like Flu Shot – HealthDay
Série de casos | Níveis mais altos de troponina foram associados com lesões cardíacas persistentes em RM em crianças com miocardite após vacinação contra COVID-19 baseada em mRNA
31 Jan, 2023 | 12:27h
Breve revisão e algoritmo | Tratamento da tuberculose latente
23 Jan, 2023 | 13:31hManagement of Latent Tuberculosis Infection – JAMA (gratuito por tempo limitado)
OMS atualiza diretrizes de COVID-19 sobre máscaras, tratamentos e cuidados do paciente
16 Jan, 2023 | 11:17hWHO updates COVID-19 guidelines on masks, treatments and patient care – World Health Organization
Diretrizes OMS atualizadas:
Therapeutics and COVID-19: Living guideline, 13 January 2023 – World Health Organization
Estudo randomizado | Fluvoxamina não é melhor que placebo em pacientes ambulatoriais com COVID-19 leve a moderada
16 Jan, 2023 | 11:12hEditorial: Lack of Benefit of Fluvoxamine for COVID-19 – JAMA
Entrevista com a autora: Fluvoxamine vs Placebo and Time to Sustained Recovery From Mild or Moderate COVID-19 – JAMA
Comentário: Trial finds that fluvoxamine doesn’t speed COVID recovery – CIDRAP
Comentário no Twitter
Among outpatients with mild to moderate #COVID19, treatment with 50 mg of fluvoxamine twice daily for 10 days, compared with placebo, did not improve time to sustained recovery. https://t.co/4QgBssqFSU pic.twitter.com/RMZ6mqlx6u
— JAMA (@JAMA_current) January 12, 2023
Revisão | COVID longa: principais achados, mecanismos e recomendações
16 Jan, 2023 | 11:08hLong COVID: major findings, mechanisms and recommendations – Nature Reviews Microbiology
Conteúdo relacionado: Retrospective Study | Most patients with long Covid developed after mild infection get better within a year
Uma pesquisa sobre a aceitação da vacina contra COVID-19 em 23 países em 2022
16 Jan, 2023 | 11:07hA survey of COVID-19 vaccine acceptance across 23 countries in 2022 – Nature Medicine
Comunicado de imprensa: Global COVID-19 vaccine acceptance rising but hesitancy remains – London School of Hygiene & Tropical Medicine
Comentário no Twitter
The third annual iteration of a survey assessing vaccine confidence in 23 countries shows the overall willingness to accept a COVID-19 vaccine has increased, although results were heteregeous across countries, according to a @NatureMedicine paper. https://t.co/0EkMH7oRdn pic.twitter.com/bLc98F9AYt
— Nature Portfolio (@NaturePortfolio) January 13, 2023
Melhores artigos de 2022 sobre doenças infecciosas – Uma revisão de fim de ano da literatura não COVID
16 Jan, 2023 | 11:06h
Comentário no Twitter
🔥🔥NEW 🔥🔥
Our new post, a great collaboration w 🌟 @IDstewardship
Best Infectious Diseases Articles From 2022 – A Year End Review Of Non-COVID Literature
1️⃣7️⃣⚡️🆔 RCTs @NEJM @TheLancet ✨
2️⃣syst Rev
3️⃣🌏Guidelines @Wiki_Guidelines
#IDTwitter #TwitteRxhttps://t.co/JL07NLa3BV pic.twitter.com/Qcf2cwK8Sd— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 4, 2023
Relatório da OMS sinaliza uma crescente resistência a antibióticos nas infecções bacterianas em humanos.
13 Dez, 2022 | 15:20hComunicado de imprensa: Report signals increasing resistance to antibiotics in bacterial infections in humans and need for better data – World Health Organization
Comentário: WHO report shows rising antibiotic resistance, need for better data – CIDRAP
Comentário no Twitter (fio – clique para saber mais)
New WHO report on #AntimicrobialResistance reveals very high levels of resistance in common bacteria frequently causing bloodstream infections in hospitals.
Infection prevention & control is critical to stop the spread and save lives.
More: https://t.co/8dGqw5KgZT pic.twitter.com/XGC2I7KbwB
— World Health Organization (WHO) (@WHO) December 9, 2022
Estudo randomizado | Uso de zinco por via oral 2 vezes/dia no tratamento de pacientes com COVID-19.
13 Dez, 2022 | 15:16h